Skip to content
Companies

Science

Brain-computer interface devices for vision loss

Raised to date

$333.7M

of $360M offered across 2 Form D filings

Still open
$26.3M
Investors
29
Last filed
Mar 6, 2026

About

Science Corporation is a clinical-stage medical technology firm dedicated to advancing brain-computer interface (BCI) technology and neural engineering. They aim to provide solutions for severe, unmet medical needs by addressing significant challenges in neuroscience.

Vertically integrated MEMS fabrication

Funding

$250M, first sold Feb 2026$230M sold$20M still openMar 20252026
Now
  • EquityFiled Mar 6, 2026Form D
    $230M/ $250M
  • DebtFiled Apr 14, 2025Form D
    $103.6M/ $110M

Product

Investigational BCI Medical Devices

Medical Devices

Science Corporation develops investigational medical devices that use brain-computer interface (BCI) technology to address conditions like vision loss, cognitive impairments, and mobility deficits. These devices are designed to interface directly with the nervous system to restore function and enhance human capabilities, although all devices are currently in the investigational stage.

  • Neural Interface Technology
  • Focus on Restorative Function
  • Advanced Neural Engineering

Built for

Patients with Neurological Disorders and Vision Loss, Medical Researchers

People on file